}tP8td#\D[X"A\v+ُ/i7=Fgj)f\t Щp)$ߴ(H)BY*γ|rܯ|vb=J$'ľf5)#}`?ǁ1n$p*Ȟ,
^J@8X0p߷|h=q
ze7XE%A{)!ٚd|ʙ^uCy_C}H㛳[=FyPp)@,
d 3UO
endstream
endobj
1411 0 obj
<>
endobj
2007 0 obj
[/ICCBased 2015 0 R]
endobj
2015 0 obj
<>stream
HyTSwoɞc
[5laQIBHADED2mtFOE.c}088GNg9w߽ '0 ֠Jb
2y.-;!KZ ^i"L0-
@8(r;q7Ly&Qq4j|9
V)gB0iW8#8wթ8_٥ʨQQj@&A)/g>'K t;\
ӥ$պFZUn(4T%)뫔0C&Zi8bxEB;Pӓ̹Aom?W=
x- [ 0}y)7ta>jT7@tܛ`q2ʀ&6ZLĄ?_yxg)˔zçLU*uSkSeO4?c. R
߁-25 S>ӣVd`rn~Y&+`;A4 A9 =-tl`;~p Gp| [`L`< "AYA+Cb(R, *T2B-
ꇆnQt}MA0alSx k&^>0|>_',G!"F$H:R!zFQd?r9\A&GrQhE]a4zBgE#H *B=0HIpp0MxJ$D1D, VĭKĻYdE"EI2EBGt4MzNr!YK ?%_(0J:EAiQ(()ӔWT6U@P+!~mDeԴ!hӦh/']B/ҏӿ?a0nhF!X8܌kc&5S6lIa2cKMA!E#ƒdV(kel
}}Cq9
N')].uJr
wG xR^[oƜchg`>b$*~ :Eb~,m,-ݖ,Y¬*6X[ݱF=3뭷Y~dó tizf6~`{v.Ng#{}}jc1X6fm;'_9 r:8q:˜O:ϸ8uJqnv=MmR 4
n3ܣkGݯz=[==<=GTB(/S,]6*-W:#7*e^YDY}UjAyT`#D="b{ų+ʯ:!kJ4Gmt}uC%K7YVfFY.=b?SƕƩȺy
چk5%4m7lqlioZlG+Zzmzy]?uuw|"űNwW&e֥ﺱ*|j5kyݭǯg^ykEklD_p߶7Dmo꿻1ml{Mś
nLl<9O [$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD- u`ֲK³8%yhYѹJº;.!
zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs
2F[p(@Xr4Pm8Ww)Km
endstream
endobj
2489 0 obj
<>stream
BT
/CS0 cs 0.247 0.247 0.243 scn
/T1_0 1 Tf
0.0106 Tc 3 Tr 11.2 0 0 11.2 531.23 748.09 Tm
(94 )Tj
-0.0072 Tc -33.987 -4.629 Td
(152)Tj
0.357 0.361 0.361 scn
0 Tc 1.557 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0404 Tc 0.832 0 Td
(Yamamoto )Tj
0 Tc 5.377 0 Td
(K)Tj
0.357 0.361 0.361 scn
0.781 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0255 Tc 0.887 0 Td
(Ichijo )Tj
0 Tc 3.11 0 Td
(H)Tj
0.357 0.361 0.361 scn
0.781 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0399 Tc 0.847 0 Td
(Korsmeyer )Tj
-0.0017 Tc 5.387 0 Td
(SJ. )Tj
0.0295 Tc 1.899 0 Td
(BCL-2 )Tj
-0.0284 Tc 3.575 0 Td
(is )Tj
0.0327 Tc 1.274 0 Td
(phosphorylated )Tj
0.0126 Tc 7.21 0 Td
(and )Tj
0.0243 Tc -36.727 -1.242 Td
(inactivated )Tj
0.0382 Tc 5.109 0 Td
(by )Tj
-0.0105 Tc 1.511 0 Td
(an )Tj
0.05 Tc 11.2311 0 0 11.2 205.18 682.33 Tm
(ASK)Tj
0.357 0.361 0.361 scn
13.4522 0 0 11.2 230.28 682.33 Tm
(l/)Tj
0.247 0.247 0.243 scn
0.0489 Tc 11.2 0 0 11.2 238.5 682.33 Tm
(Jun )Tj
0.0274 Tc 1.938 0 Td
(N-terminal )Tj
0.0298 Tc 5.162 0 Td
(protein )Tj
0.0255 Tc 3.489 0 Td
(kinase )Tj
0.0373 Tc 3.175 0 Td
(pathway )Tj
0.0301 Tc 4.069 0 Td
(normally )Tj
0.0251 Tc 4.298 0 Td
(activated )Tj
-0.0018 Tc 4.286 0 Td
(at )Tj
0.0185 Tc -37.5 -1.243 Td
(G\(2\))Tj
0.58 0.58 0.58 scn
0 Tc 2.003 0 Td
(/)Tj
0.247 0.247 0.243 scn
0.0073 Tc 0.296 0 Td
(M. )Tj
0.0321 Tc 1.5 0 Td
(Mol.Cell )Tj
0.0218 Tc 4.114 0 Td
(Biol. )Tj
0.0111 Tc 2.477 0 Td
(1999; )Tj
-0.0286 Tc 2.464 0 Td
(19)Tj
0.357 0.361 0.361 scn
0 Tc 1.038 0 Td
(:)Tj
0.247 0.247 0.243 scn
0.0289 Tc 0.286 0 Td
(8469-78)Tj
0.58 0.58 0.58 scn
0 Tc 3.597 0 Td
(. )Tj
0.247 0.247 0.243 scn
-0.0179 Tc -14.543 -2.507 Td
(153)Tj
0.357 0.361 0.361 scn
0 Tc 1.557 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0325 Tc 0.596 0 Td
(Wasielewski )Tj
0 Tc 5.871 0 Td
(M)Tj
0.357 0.361 0.361 scn
0.974 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0306 Tc 0.632 0 Td
(Elstrodt )Tj
0 Tc 3.772 0 Td
(F)Tj
0.58 0.58 0.58 scn
0.61 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.023 Tc 0.633 0 Td
(Klijn )Tj
0.05 Tc 11.2417 0 0 11.2 343.14 640.33 Tm
(JG)Tj
0.357 0.361 0.361 scn
0 Tc 11.2 0 0 11.2 356.94 640.33 Tm
(, )Tj
0.247 0.247 0.243 scn
0.05 Tc 11.2841 0 0 11.2 363.79 640.33 Tm
(Bems )Tj
11.2489 0 0 11.2 395.94 640.33 Tm
(EM)Tj
0.357 0.361 0.361 scn
0 Tc 11.2 0 0 11.2 414.06 640.33 Tm
(, )Tj
0.247 0.247 0.243 scn
0.0279 Tc 0.641 0 Td
(Schutte )Tj
0 Tc 3.571 0 Td
(M)Tj
0.357 0.361 0.361 scn
0.991 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0272 Tc 0.569 0 Td
(Thirteen )Tj
0.0156 Tc 3.994 0 Td
(new )Tj
0.0045 Tc -36.533 -1.243 Td
(p53 )Tj
0.0262 Tc 2.046 0 Td
(gene )Tj
0.0307 Tc 2.45 0 Td
(mutants )Tj
0.0266 Tc 3.851 0 Td
(identified )Tj
0.046 Tc 4.541 0 Td
(among )Tj
-0.035 Tc 10.6139 0 0 11.2 296.12 626.41 Tm
(41 )Tj
0.0281 Tc 11.2 0 0 11.2 313.42 626.41 Tm
(human )Tj
0.0349 Tc 3.346 0 Td
(breast )Tj
0.0359 Tc 3.011 0 Td
(cancer )Tj
0.0124 Tc 3.236 0 Td
(cell )Tj
0.0044 Tc 2.015 0 Td
(lines. )Tj
0.0298 Tc 2.704 0 Td
(Breast )Tj
0.0387 Tc 3.144 0 Td
(Cancer )Tj
0.0236 Tc -35.244 -1.222 Td
(Res)Tj
0.58 0.58 0.58 scn
0 Tc 1.634 0 Td
(.)Tj
0.247 0.247 0.243 scn
0.0121 Tc 0.247 0 Td
(Treat. )Tj
0.0325 Tc 2.788 0 Td
(2006)Tj
0.357 0.361 0.361 scn
0 Tc 2.171 0 Td
(;)Tj
0.247 0.247 0.243 scn
0.0278 Tc 0.287 0 Td
(99:97-101. )Tj
-0.0072 Tc -3.859 -2.506 Td
(154)Tj
0.357 0.361 0.361 scn
0 Tc 1.536 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0401 Tc 0.746 0 Td
(Yaginuma )Tj
0 Tc 5.014 0 Td
(Y)Tj
0.357 0.361 0.361 scn
0.779 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0345 Tc 0.784 0 Td
(Westphal )Tj
-0.018 Tc 4.606 0 Td
(H. )Tj
0.0278 Tc 1.567 0 Td
(Analysis )Tj
0.05 Tc 12.5203 0 0 11.2 367.32 584.65 Tm
(of )Tj
0.0126 Tc 11.2 0 0 11.2 383.25 584.65 Tm
(the )Tj
0.0045 Tc 1.826 0 Td
(p53 )Tj
0.0262 Tc 2.132 0 Td
(gene )Tj
/T1_1 1 Tf
0.05 Tc 9.5874 0 0 7.8001 455.98 584.65 Tm
(III )Tj
/T1_0 1 Tf
0.0281 Tc 11.2 0 0 11.2 471.34 584.65 Tm
(human )Tj
0.0201 Tc 3.409 0 Td
(uterine )Tj
0.0317 Tc -35.281 -1.244 Td
(carcinoma )Tj
0.0478 Tc 4.714 0 Td
(celllines. )Tj
0.043 Tc 4.392 0 Td
(Cancer )Tj
0.011 Tc 3.306 0 Td
(Res. )Tj
-0.0143 Tc 2.241 0 Td
(1991 )Tj
0.357 0.361 0.361 scn
0 Tc 2.093 0 Td
(;)Tj
0.247 0.247 0.243 scn
0.0316 Tc 0.306 0 Td
(51:6506-9)Tj
0.58 0.58 0.58 scn
0 Tc 4.429 0 Td
(. )Tj
0.247 0.247 0.243 scn
-0.0179 Tc -18.271 -2.485 Td
(155)Tj
0.357 0.361 0.361 scn
0 Tc 1.557 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0313 Tc 0.588 0 Td
(Cao )Tj
0 Tc 2.044 0 Td
(Y)Tj
0.357 0.361 0.361 scn
0.801 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0429 Tc 0.585 0 Td
(Gao )Tj
0 Tc 11.7 0 0 11.7 236.52 542.89 Tm
(Q)Tj
0.357 0.361 0.361 scn
0.754 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0468 Tc 11.2 0 0 11.2 252.2 542.89 Tm
(Wazer )Tj
0.05 Tc 11.2491 0 0 11.2 287.47 542.89 Tm
(DE)Tj
0.357 0.361 0.361 scn
0 Tc 11.2 0 0 11.2 303.66 542.89 Tm
(, )Tj
0.247 0.247 0.243 scn
0.0471 Tc 0.59 0 Td
(Band )Tj
-0.035 Tc 10.8343 0 0 11.2 339.82 542.89 Tm
(V. )Tj
0.0353 Tc 11.2 0 0 11.2 354.94 542.89 Tm
(Abrogation )Tj
0.05 Tc 12.5203 0 0 11.2 413.64 542.89 Tm
(of )Tj
0.0282 Tc 11.2 0 0 11.2 427.18 542.89 Tm
(wild-type )Tj
0.0274 Tc 4.461 0 Td
(p53-mediated )Tj
0.0241 Tc -32.383 -1.221 Td
(transactivation )Tj
-0.007 Tc 6.616 0 Td
(is )Tj
0.0282 Tc 1.071 0 Td
(insufficient )Tj
0.0181 Tc 5.226 0 Td
(for )Tj
0.0375 Tc 1.595 0 Td
(mutant )Tj
0.0327 Tc 3.346 0 Td
(p53-induced )Tj
0.0308 Tc 5.712 0 Td
(immortalization )Tj
0.05 Tc 12.5203 0 0 11.2 459 529.21 Tm
(of )Tj
0.0261 Tc 11.2 0 0 11.2 472.79 529.21 Tm
(normal )Tj
0.0335 Tc 3.342 0 Td
(human )Tj
0.0436 Tc -35.379 -1.243 Td
(mammary )Tj
0.0252 Tc 4.62 0 Td
(epithelial )Tj
0.0192 Tc 4.265 0 Td
(cells)Tj
0.357 0.361 0.361 scn
0 Tc 2.004 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0387 Tc 0.524 0 Td
(Cancer )Tj
0.0236 Tc 3.306 0 Td
(Res )Tj
0.0071 Tc 1.984 0 Td
(1997)Tj
0.357 0.361 0.361 scn
0 Tc 2.093 0 Td
(;)Tj
0.247 0.247 0.243 scn
0.0316 Tc 0.285 0 Td
(57:5584-9)Tj
0.357 0.361 0.361 scn
0 Tc 4.429 0 Td
(. )Tj
0.247 0.247 0.243 scn
-0.0072 Tc -20.264 -2.507 Td
(156)Tj
0.357 0.361 0.361 scn
0 Tc 1.557 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0295 Tc 0.53 0 Td
(Henkel)Tj
0.357 0.361 0.361 scn
0 Tc 3.097 0 Td
(s )Tj
0.247 0.247 0.243 scn
0.05 Tc 11.285 0 0 11.2 216.43 487.21 Tm
(KM)Tj
0.357 0.361 0.361 scn
0 Tc 11.2 0 0 11.2 235.98 487.21 Tm
(, )Tj
0.247 0.247 0.243 scn
0.0278 Tc 0.543 0 Td
(Turchi )Tj
-0.035 Tc 9.6688 0 0 11.2 277.35 487.21 Tm
(11)Tj
0.357 0.361 0.361 scn
0 Tc 11.2 0 0 11.2 287.53 487.21 Tm
(. )Tj
0.247 0.247 0.243 scn
0.0302 Tc 0.546 0 Td
(Cisplatin-induced )Tj
0.0277 Tc 7.929 0 Td
(apoptosis )Tj
0.0297 Tc 4.34 0 Td
(proceeds )Tj
0.05 Tc 11.3034 0 0 11.2 476.89 487.21 Tm
(by )Tj
0.0219 Tc 11.2 0 0 11.2 492.37 487.21 Tm
(caspase-3-)Tj
0.0316 Tc -33.771 -1.222 Td
(dependent )Tj
0.0126 Tc 4.671 0 Td
(and )Tj
0.0364 Tc 1.798 0 Td
(-independent )Tj
0.0346 Tc 5.906 0 Td
(pathways )Tj
0.0106 Tc 4.362 0 Td
(in )Tj
0.0276 Tc 1.112 0 Td
(cisplatin-resistant )Tj
0.0233 Tc 7.843 0 Td
(and )Tj
0 Tc 1.82 0 Td
(-)Tj
0.357 0.361 0.361 scn
0.362 0 Td
(s)Tj
0.247 0.247 0.243 scn
0.0171 Tc 0.411 0 Td
(ensiti)Tj
0.357 0.361 0.361 scn
0 Tc 2.323 0 Td
(v)Tj
0.247 0.247 0.243 scn
0.548 0 Td
(e )Tj
0.0281 Tc 0.737 0 Td
(human )Tj
0 Tc 3.185 0 Td
(o)Tj
0.357 0.361 0.361 scn
0.522 0 Td
(v)Tj
0.247 0.247 0.243 scn
0.0073 Tc 0.549 0 Td
(arian )Tj
0.0316 Tc -36.15 -1.242 Td
(cancer )Tj
0.05 Tc 11.2034 0 0 11.2 148.21 459.61 Tm
(celllines. )Tj
0.0387 Tc 11.2 0 0 11.2 197.4 459.61 Tm
(Cancer )Tj
0.011 Tc 3.306 0 Td
(Res. )Tj
0.0264 Tc 2.241 0 Td
(1999;59)Tj
0.357 0.361 0.361 scn
0 Tc 3.503 0 Td
(:)Tj
0.247 0.247 0.243 scn
0.0257 Tc 0.271 0 Td
(3077-83)Tj
0.357 0.361 0.361 scn
0 Tc 3.612 0 Td
(. )Tj
0.247 0.247 0.243 scn
-0.0024 Tc -17.157 -2.465 Td
(157. )Tj
0.0303 Tc 2.266 0 Td
(Salvesen )Tj
0.0228 Tc 4.23 0 Td
(GS)Tj
0.357 0.361 0.361 scn
0 Tc 1.387 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0319 Tc 0.697 0 Td
(Renatus )Tj
0.0073 Tc 3.9 0 Td
(M. )Tj
0.0299 Tc 1.674 0 Td
(Apoptosome: )Tj
0.0126 Tc 6.235 0 Td
(the )Tj
0.0318 Tc 1.746 0 Td
(seven-spoked )Tj
0.024 Tc 6.262 0 Td
(death )Tj
0.0298 Tc 2.751 0 Td
(machine)Tj
0.357 0.361 0.361 scn
0 Tc 3.646 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0218 Tc -38.02 -1.243 Td
(Dev.Cell. )Tj
0.0253 Tc 4.37 0 Td
(2002)Tj
0.357 0.361 0.361 scn
0 Tc 2.171 0 Td
(;)Tj
0.247 0.247 0.243 scn
0.271 0 Td
(2)Tj
0.357 0.361 0.361 scn
0.581 0 Td
(:)Tj
0.247 0.247 0.243 scn
0.0322 Tc 0.254 0 Td
(256-7)Tj
0.357 0.361 0.361 scn
0 Tc 2.536 0 Td
(. )Tj
0.247 0.247 0.243 scn
-0.0024 Tc -6.957 -2.486 Td
(158. )Tj
-0.035 Tc 10.8604 0 0 11.2 174.66 390.24 Tm
(Li )Tj
0 Tc 11.2 0 0 11.2 189.34 390.24 Tm
(X)Tj
0.357 0.361 0.361 scn
0.779 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0497 Tc 0.634 0 Td
(Wang )Tj
-0.002 Tc 2.938 0 Td
(X. )Tj
0.0347 Tc 1.436 0 Td
(Application )Tj
0.05 Tc 12.5203 0 0 11.2 315.48 390.24 Tm
(of )Tj
0.0291 Tc 11.2 0 0 11.2 329.5 390.24 Tm
(real-time )Tj
0.0346 Tc 4.268 0 Td
(polymerase )Tj
0.0321 Tc 5.324 0 Td
(chain )Tj
0.0243 Tc 2.708 0 Td
(reaction )Tj
0.0074 Tc 3.827 0 Td
(for )Tj
0.0126 Tc 1.594 0 Td
(the )Tj
0.025 Tc -36.971 -1.242 Td
(quantitation )Tj
0.05 Tc 12.5203 0 0 11.2 174.84 376.33 Tm
(of )Tj
0.0381 Tc 11.2 0 0 11.2 188.55 376.33 Tm
(interleukin-l )Tj
0.0417 Tc 5.537 0 Td
(beta )Tj
0.05 Tc 11.2381 0 0 11.2 274.54 376.33 Tm
(mRNA )Tj
0.0319 Tc 11.2 0 0 11.2 313.2 376.33 Tm
(upregulation )Tj
0.0106 Tc 5.778 0 Td
(in )Tj
0.0302 Tc 1.145 0 Td
(brain )Tj
0.031 Tc 2.541 0 Td
(ischemic )Tj
0.0159 Tc 4.141 0 Td
(tolerance. )Tj
0.0292 Tc 4.477 0 Td
(Brain )Tj
0.0267 Tc -35.871 -1.221 Td
(Res.Brain )Tj
0.0236 Tc 4.499 0 Td
(Res)Tj
0.357 0.361 0.361 scn
0 Tc 1.634 0 Td
(.)Tj
0.247 0.247 0.243 scn
0.0225 Tc 0.23 0 Td
(Protoc. )Tj
0.0396 Tc 3.362 0 Td
(2000)Tj
0.357 0.361 0.361 scn
0 Tc 2.193 0 Td
(;)Tj
0.247 0.247 0.243 scn
0.285 0 Td
(5 )Tj
0.0139 Tc 0.59 0 Td
(:211-7. )Tj
-0.0072 Tc -9.567 -2.507 Td
(159)Tj
0.357 0.361 0.361 scn
0 Tc 1.557 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0165 Tc 0.658 0 Td
(Lu )Tj
0 Tc 1.608 0 Td
(D)Tj
0.357 0.361 0.361 scn
0.781 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0437 Tc 0.676 0 Td
(Huang )Tj
0 Tc 3.299 0 Td
(J)Tj
0.357 0.361 0.361 scn
0.439 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0412 Tc 0.697 0 Td
(Basu )Tj
/T1_1 1 Tf
0.0073 Tc 11.1 0 0 11.1 287.77 334.57 Tm
(A. )Tj
/T1_0 1 Tf
0.0323 Tc 11.2 0 0 11.2 304.03 334.57 Tm
(Protein )Tj
0.0255 Tc 3.538 0 Td
(kinase )Tj
0.0283 Tc 3.163 0 Td
(Cepsilon )Tj
0.0229 Tc 4.265 0 Td
(activates )Tj
0.0298 Tc 4.147 0 Td
(protein )Tj
0.0212 Tc 3.446 0 Td
(kinase )Tj
0 Tc -35.553 -1.221 Td
(B)Tj
0.58 0.58 0.58 scn
0.69 0 Td
(/)Tj
0.247 0.247 0.243 scn
0.0355 Tc 0.32 0 Td
(Akt )Tj
0.0249 Tc 2.036 0 Td
(via )Tj
0.05 Tc 11.2507 0 0 11.2 167.23 320.89 Tm
(DNA-PK )Tj
-0.0032 Tc 11.2 0 0 11.2 217.65 320.89 Tm
(to )Tj
0.0286 Tc 1.269 0 Td
(protect )Tj
0.0303 Tc 3.417 0 Td
(against )Tj
0.036 Tc 3.5 0 Td
(tumor )Tj
0.0287 Tc 2.959 0 Td
(necrosis )Tj
0.028 Tc 3.976 0 Td
(factor-alpha-induced )Tj
0.0124 Tc 9.344 0 Td
(cell )Tj
0.0186 Tc 1.95 0 Td
(death)Tj
0.357 0.361 0.361 scn
0 Tc 2.325 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0062 Tc -38.021 -1.244 Td
(J.Bio1.Chem. )Tj
0.0203 Tc 5.913 0 Td
(2006;281 )Tj
0.357 0.361 0.361 scn
0 Tc 4.096 0 Td
(:)Tj
0.247 0.247 0.243 scn
0.034 Tc 0.276 0 Td
(22799-807)Tj
0.357 0.361 0.361 scn
0 Tc 4.679 0 Td
(. )Tj
0.247 0.247 0.243 scn
-0.0095 Tc -11.715 -2.485 Td
(160. )Tj
-0.035 Tc 11.1462 0 0 11.2 174.9 279.13 Tm
(Li )Tj
0 Tc 11.2 0 0 11.2 190.26 279.13 Tm
(L)Tj
0.357 0.361 0.361 scn
0.632 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.042 Tc 0.705 0 Td
(Sampat )Tj
-0.0056 Tc 3.635 0 Td
(K, )Tj
0.05 Tc 11.2306 0 0 11.2 262.51 279.13 Tm
(Hu )Tj
0 Tc 11.2 0 0 11.2 281.81 279.13 Tm
(N)Tj
0.357 0.361 0.361 scn
0.794 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0212 Tc 0.677 0 Td
(Zakari )Tj
0 Tc 3.213 0 Td
(J)Tj
0.357 0.361 0.361 scn
0.461 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0383 Tc 0.678 0 Td
(Yuspa )Tj
0.0208 Tc 3.178 0 Td
(SH)Tj
0.357 0.361 0.361 scn
0 Tc 1.369 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0323 Tc 0.657 0 Td
(Protein )Tj
0.0298 Tc 3.517 0 Td
(kinase )Tj
0 Tc 3.163 0 Td
(C )Tj
0.0262 Tc 1.124 0 Td
(negatively )Tj
0.0208 Tc -33.837 -1.243 Td
(regulates )Tj
0.0355 Tc 4.371 0 Td
(Akt )Tj
0.0269 Tc 2.113 0 Td
(activity )Tj
0.034 Tc 3.729 0 Td
(and )Tj
0.0308 Tc 2.065 0 Td
(modifies )Tj
0.0399 Tc 4.287 0 Td
(UYC-induced )Tj
0.025 Tc 6.548 0 Td
(apoptosis )Tj
-0.0109 Tc 4.566 0 Td
(in )Tj
0.0346 Tc 1.335 0 Td
(mouse )Tj
0.0196 Tc 3.3 0 Td
(keratinocytes. )Tj
0 Tc -32.318 -1.243 Td
(J)Tj
0.357 0.361 0.361 scn
0.456 0 Td
(.)Tj
0.247 0.247 0.243 scn
0.0341 Tc 0.23 0 Td
(Biol.Chem)Tj
0.357 0.361 0.361 scn
0 Tc 4.698 0 Td
(.)Tj
0.247 0.247 0.243 scn
0.0325 Tc 0.507 0 Td
(2006)Tj
0.357 0.361 0.361 scn
0 Tc 2.193 0 Td
(;)Tj
0.247 0.247 0.243 scn
0.0287 Tc 0.271 0 Td
(281:3237-43. )Tj
-0.0167 Tc -5.107 -2.486 Td
(161. )Tj
-0.0049 Tc 2.322 0 Td
(Lu )Tj
0 Tc 1.672 0 Td
(D)Tj
0.357 0.361 0.361 scn
0.781 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.049 Tc 0.762 0 Td
(Huang )Tj
0 Tc 3.385 0 Td
(J)Tj
0.357 0.361 0.361 scn
0.461 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0341 Tc 0.783 0 Td
(Basu )Tj
0 Tc 2.66 0 Td
(A)Tj
0.357 0.361 0.361 scn
0.796 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.032 Tc 0.766 0 Td
(Deregulation )Tj
0.05 Tc 12.2421 0 0 11.2 380.04 223.45 Tm
(of )Tj
0.0321 Tc 11.2 0 0 11.2 395.71 223.45 Tm
(PKB )Tj
0.0243 Tc 2.611 0 Td
(influences )Tj
0.0236 Tc 4.905 0 Td
(antiapoptotic )Tj
0.0274 Tc -32.704 -1.222 Td
(signaling )Tj
0.0382 Tc 4.194 0 Td
(by )Tj
0.0428 Tc 1.344 0 Td
(PKC )Tj
-0.0109 Tc 2.375 0 Td
(in )Tj
0.0306 Tc 1.102 0 Td
(breast )Tj
0.0402 Tc 2.839 0 Td
(cancer )Tj
0.0192 Tc 3.086 0 Td
(cells)Tj
0.357 0.361 0.361 scn
0 Tc 1.982 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.05 Tc 12.1442 0 0 11.2 309.27 209.76 Tm
(InU)Tj
0.357 0.361 0.361 scn
0 Tc 11.2 0 0 11.2 330.49 209.76 Tm
(.)Tj
0.247 0.247 0.243 scn
0.0189 Tc 0.246 0 Td
(Oncol. )Tj
0.0324 Tc 3.154 0 Td
(2004;25:671-6)Tj
0.357 0.361 0.361 scn
0 Tc 6.35 0 Td
(. )Tj
0.247 0.247 0.243 scn
-0.0095 Tc -25.879 -2.485 Td
(162. )Tj
0.0343 Tc 2.124 0 Td
(Cully )Tj
0 Tc 2.685 0 Td
(M)Tj
0.357 0.361 0.361 scn
0.996 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0427 Tc 0.571 0 Td
(You )Tj
0 Tc 2.184 0 Td
(H)Tj
0.357 0.361 0.361 scn
0.803 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.035 Tc 0.589 0 Td
(Levine )Tj
0.0305 Tc 3.304 0 Td
(AJ)Tj
0.357 0.361 0.361 scn
0 Tc 1.229 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.05 Tc 11.3665 0 0 11.2 318.43 181.93 Tm
(Mak )Tj
0.0282 Tc 11.2 0 0 11.2 344.06 181.93 Tm
(TW. )Tj
0.0425 Tc 2.276 0 Td
(Beyond )Tj
0.0439 Tc 3.664 0 Td
(PTEN )Tj
0.0224 Tc 3.024 0 Td
(mutations: )Tj
0.0019 Tc 4.863 0 Td
(the )Tj
0.03 Tc 1.606 0 Td
(PI3K )Tj
0.0373 Tc -36.015 -1.221 Td
(pathway )Tj
-0.0281 Tc 4.21 0 Td
(as )Tj
-0.0105 Tc 1.479 0 Td
(an )Tj
0.0299 Tc 1.609 0 Td
(integrator )Tj
0.05 Tc 12.5203 0 0 11.2 248.52 168.25 Tm
(of )Tj
0.0303 Tc 11.2 0 0 11.2 265.18 168.25 Tm
(multiple )Tj
0.0203 Tc 4.194 0 Td
(inputs )Tj
0.0284 Tc 3.191 0 Td
(during )Tj
0.0245 Tc 3.393 0 Td
(tumorigenesis. )Tj
0.0255 Tc 6.843 0 Td
(Nat.Rev.Cancer. )Tj
0.0192 Tc -31.168 -1.243 Td
(2006;6: )Tj
0.0124 Tc 3.357 0 Td
(184-92. )Tj
-0.0286 Tc -0.107 -2.465 Td
(163)Tj
0.357 0.361 0.361 scn
0 Tc 1.536 0 Td
(. )Tj
0.247 0.247 0.243 scn
0.0439 Tc 0.725 0 Td
(Yamazawa )Tj
0 Tc 5.27 0 Td
(K)Tj
0.357 0.361 0.361 scn
0.781 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0409 Tc 0.769 0 Td
(Shimada )Tj
0 Tc 4.257 0 Td
(H)Tj
0.357 0.361 0.361 scn
0.76 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0148 Tc 0.762 0 Td
(Hirai )Tj
0 Tc 2.7 0 Td
(M)Tj
0.357 0.361 0.361 scn
0.953 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0268 Tc 0.74 0 Td
(Hirashiki )Tj
0 Tc 4.521 0 Td
(K)Tj
0.357 0.361 0.361 scn
0.781 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0206 Tc 0.734 0 Td
(Ochiai )Tj
0 Tc 3.322 0 Td
(T)Tj
0.357 0.361 0.361 scn
0.679 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0291 Tc 0.757 0 Td
(lshikura )Tj
0 Tc 3.947 0 Td
(H)Tj
0.357 0.361 0.361 scn
0.781 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0267 Tc -37.996 -1.242 Td
(Shozu )Tj
0 Tc 2.971 0 Td
(M)Tj
0.357 0.361 0.361 scn
0.953 0 Td
(, )Tj
0.247 0.247 0.243 scn
0.0372 Tc 0.607 0 Td
(lsaka )Tj
-0.035 Tc 11.0393 0 0 11.2 193.15 112.81 Tm
(K. )Tj
0.0421 Tc 11.2 0 0 11.2 208.6 112.81 Tm
(Serum )Tj
0.0045 Tc 3.148 0 Td
(p53 )Tj
0.0316 Tc 1.938 0 Td
(antibody )Tj
-0.0067 Tc 4.093 0 Td
(as )Tj
0 Tc 1.221 0 Td
(a )Tj
0.0281 Tc 0.771 0 Td
(diagnostic )Tj
0.0394 Tc 4.744 0 Td
(marker )Tj
0.05 Tc 12.5203 0 0 11.2 424.68 112.81 Tm
(of )Tj
0.0187 Tc 11.2 0 0 11.2 438.22 112.81 Tm
(high-ri)Tj
0.357 0.361 0.361 scn
0 Tc 2.923 0 Td
(s)Tj
0.247 0.247 0.243 scn
0.42 0 Td
(k )Tj
0.0221 Tc 0.87 0 Td
(endometrial )Tj
0.0168 Tc -33.213 -1.244 Td
(cancer. )Tj
0.0185 Tc 3.329 0 Td
(Am.J.Obstet.Gyneco1. )Tj
0.0325 Tc 9.831 0 Td
(2007)Tj
0.357 0.361 0.361 scn
0 Tc 2.171 0 Td
(;)Tj
0.247 0.247 0.243 scn
0.0202 Tc 0.393 0 Td
(197:505-7)Tj
0.357 0.361 0.361 scn
0 Tc 4.343 0 Td
(. )Tj
ET
q
/CS0 cs 0.159 0.159 0.159 scn
495.3600006 0 0 660.4799957 49.9199982 95.7359924 cm
/Im0 Do
Q
endstream
endobj
1407 0 obj
<>/Filter/JBIG2Decode/Height 2752/ImageMask true/Length 4410/Subtype/Image/Width 2064>>stream
0
@
^ƸB0PZ#q$ ]ۂy `0CaN
__ĴT9^ɣ"P"9hoN#um\aj.ILP5!QB#Uܛ<N{B
Fd>qsڲs};ZVVՌ4
NaK#h_^Z`,-uն҅?Sk9/ c߆l/!Q+ dw'=r~tvBϽ_Ё$CHg9Q{,ˢ#>j t%7De$$|5{ȶcRȭ=|~AA+BGt7H4CpZkyn^MFt>q" JZ(s`⥥4k&c*`}|H=Q7Nc2Ulb֑:HTXD8ɮP-!cW&_O,9x?Ht .#9g
Η*_w妟gHv)-~!e8Wx]K|HvAUY`d*j$:w
Al.\6y*(lCMpiLϦ܌K>}AhcIϠ]D1&_UPͻpGNE }\E Nkw55Zz6Y0 3)s,1yA^By%B][kSvبIj +7{a%Vz:5mMIU$s>;@k2wQl2=CI,oIBfۮ۫t`q
uofrcqg*Kf26<PsTygQRx.!1TXNhQl}EǓЊz,i؊P9cT<u5kpዺB ?l@>lF/y/"GGw@2y؎%3bOmig`@?ƻ<#|< ;# ӠoqPe~
ڥiU1z?˰y#9hLBtp$"@
Wmɂޤ|VV6_1RR%
cg SS@HÃ9 )Զ?yDDJ%tMR.ȳG(bFeTܬuۻ8gk>xcHZdjE1ԚdӎfŘ|Јsotrf;5;xou3IK99؊CF:1KoՐTKh'-y
zk|11Jf&*@:<*xY7D0Ay
=%_]Vvg 5mY"uڇc/~
uzz4XAy3 =:Ə5+6Z؊j4腣
[Pud]&ڈ
4#{˧2Xfƙ
(:*n"qbׂEqp%-+Y"~dсm9i iWtTv Qג|wpwП-5E9"[D6#-K,mW+}R<[? Xġs'\wӼMlΆ>I9S!
8m9&CjRDԇl;) iUZ\8-?]:PsxiE~>Ggn){Kd^ǚآ$+w&+6VU3y?ka`t&s`_.$A>bCs#Ƕ9
24|}͙ ![xD|Ji[8 ~IχtJΊ/W:?É0%0J_µ U/,AwUeǙ<RylĄ'?/Aҡ,Er{@
H5KЀed"ˬS@~HErJ]C2L^J%U3b͉jt_4@_'|p{A) RK_&p$dPAFw9X}c68]af"}YZe(ǝ~be{d
[FĀK\:-7vZa߬pӊܘrS"W4{P&Ӎ'ћJp&imJAv)*bo[Prx%ӏ25MʬǔUHBTN2 W KLbω
ş×tQﰿmAңp(=cdqq~D[sۿ-f}O>N7˾eA0COc
|7$
GZ˽!*33 /2xA}G
)s`i.WnuCJܶk)thٟ:'j-vSmD˘}e܂ւ$;3^Q^T#d Q,GH31m'LQ
JG.b"Jz
zjgIۊ&mOŭ?;IRl4<